{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:00:55Z","timestamp":1792555255714,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2019R1I1A3A0106372612"],"award-info":[{"award-number":["2019R1I1A3A0106372612"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.cca.2023.117248","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T02:35:25Z","timestamp":1675910125000},"page":"117248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Roles and correlations of TIM-3 and LAG-3 with cytokines and chemokines in alcoholic liver disease"],"prefix":"10.1016","volume":"541","author":[{"given":"Ailyn","family":"Fadriquela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2023.117248_b0005","series-title":"World health statistics 2022: monitoring health for the SDGs, sustainable development goals","first-page":"48","year":"2022"},{"key":"10.1016\/j.cca.2023.117248_b0010","unstructured":"Alcohol: Fact Sheet, World Health Organization, 2022, https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/alcohol (accessed 01 January 2022)."},{"issue":"2","key":"10.1016\/j.cca.2023.117248_b0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2018.10.026","article-title":"Current trials and novel therapeutic targets for alcoholic hepatitis","volume":"70","author":"Singal","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2023.117248_b0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.livres.2018.11.002","article-title":"Alcoholic liver disease: a current molecular and clinical perspective","volume":"2 (4)","author":"Ohashi","year":"2018","journal-title":"Liver Res."},{"issue":"1","key":"10.1016\/j.cca.2023.117248_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02982543","article-title":"Cytokines: past, present, and future","volume":"74","author":"Oppenheim","year":"2001","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.cca.2023.117248_b0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0741-8329(00)00134-8","article-title":"Serum cytokine levels in alcohol-related liver cirrhosis","volume":"23 (1)","author":"Daniluk","year":"2001","journal-title":"Alcohol"},{"key":"10.1016\/j.cca.2023.117248_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.livres.2022.01.001","article-title":"Immune cells in alcohol-related liver disease","author":"Xu","year":"2022","journal-title":"Liver Res."},{"issue":"4","key":"10.1016\/j.cca.2023.117248_b0040","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep4.1475","article-title":"Immune checkpoint axes are dysregulated in patients with alcoholic hepatitis","volume":"4","author":"Li","year":"2020","journal-title":"Hepatol. Commun."},{"issue":"3","key":"10.1016\/j.cca.2023.117248_b0045","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/j.gastro.2014.11.041","article-title":"Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis","volume":"148","author":"Markwick","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2023.117248_b0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.alcohol.2021.10.002","article-title":"Characteristics of immune checkpoint regulators and potential role of soluble TIM-3 and LAG-3 in male patients with alcohol-associated liver disease","volume":"98","author":"Fadriquela","year":"2022","journal-title":"Alcohol"},{"key":"10.1016\/j.cca.2023.117248_b0055","doi-asserted-by":"crossref","first-page":"632502","DOI":"10.3389\/fphys.2021.632502","article-title":"Soluble TIM3 and its ligands galectin-9 and CEACAM1 are in disequilibrium during alcohol-related liver disease and promote impairment of anti-bacterial immunity","volume":"12","author":"Riva","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cca.2023.117248_b0060","first-page":"193","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75 (2)","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cca.2023.117248_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-021-02071-2","article-title":"Association of FIB-4 index and clinical outcomes in critically ill patients with acute kidney injury: a cohort study","volume":"21","author":"Shi","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.cca.2023.117248_b0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V73.1.117.117","article-title":"Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay","author":"Watari","year":"1989","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cca.2023.117248_b0075","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jcyt.2021.11.006","article-title":"Effectiveness of cell-and colony stimulating factor-based therapy for liver cirrhosis: a network meta-analysis of randomized controlled trials","volume":"24","author":"Sun","year":"2022","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.cca.2023.117248_b0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jceh.2022.06.012","article-title":"Emerging pharmacotherapies in alcohol-associated hepatitis (AH)","volume":"13","author":"Wakil","year":"2023","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.cca.2023.117248_b0085","series-title":"Insights into the Role of Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis, Seminars in Liver Disease","first-page":"67","author":"Kedarisetty","year":"2021"},{"issue":"5","key":"10.1016\/j.cca.2023.117248_b0090","doi-asserted-by":"crossref","first-page":"100139","DOI":"10.1016\/j.jhepr.2020.100139","article-title":"Granulocyte colony-stimulating factor for alcoholic hepatitis: a systematic review and meta-analysis of randomised controlled trials","volume":"2","author":"Marot","year":"2020","journal-title":"JHEP Rep"},{"issue":"10","key":"10.1016\/j.cca.2023.117248_b0095","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cgh.2018.01.040","article-title":"Efficacy of granulocyte colony-stimulating factor and N-acetylcysteine therapies in patients with severe alcoholic hepatitis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.cca.2023.117248_b0100","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.30516","article-title":"Efficacy of granulocyte colony-stimulating factor in the management of steroid-nonresponsive severe alcoholic hepatitis: a double-blind randomized controlled trial","volume":"70","author":"Shasthry","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2023.117248_b0105","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2014.07.006","article-title":"CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis","volume":"61 (6)","author":"Zhang","year":"2014","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.cca.2023.117248_b0110","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/ijms17040472","article-title":"Multiplex immunoassay of plasma cytokine levels in men with alcoholism and the relationship to psychiatric assessments","volume":"17","author":"Manzardo","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"35","key":"10.1016\/j.cca.2023.117248_b0115","doi-asserted-by":"crossref","first-page":"e1435","DOI":"10.1097\/MD.0000000000001435","article-title":"Association between IL-4 polymorphisms and risk of liver disease: an updated meta-analysis","volume":"94","author":"Wu","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.cca.2023.117248_b0120","doi-asserted-by":"crossref","first-page":"40404","DOI":"10.1038\/srep40404","article-title":"Predictive value of serum IFN-gamma inducible protein-10 and IFN-gamma\/IL-4 ratio for liver fibrosis progression in CHB patients","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cca.2023.117248_b0125","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s10517-022-05404-7","article-title":"Medicine, hepatocytic apoptosis and immune dysfunction in decompensation of alcoholic liver cirrhosis with different grades of acute-on-chronic liver failure","volume":"172","author":"Rodina","year":"2022","journal-title":"Bull. Exp. Biol."},{"key":"10.1016\/j.cca.2023.117248_b0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1726-4901(10)70004-6","article-title":"Serum interleukin-12 levels in alcoholic liver disease","volume":"73 (2)","author":"Tung","year":"2010","journal-title":"J. Chin. Med. Assoc."},{"issue":"3","key":"10.1016\/j.cca.2023.117248_b0135","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1128\/IAI.69.3.1454-1462.2001","article-title":"Interleukin-12 promotes pathologic liver changes and death in mice coinfected with Schistosoma mansoni and Toxoplasma gondii","volume":"69","author":"Araujo","year":"2001","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.cca.2023.117248_b0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hep.29242","article-title":"Alcohol abstinence ameliorates the dysregulated immune profiles in patients with alcoholic hepatitis: a prospective observational study","volume":"66","author":"Li","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cca.2023.117248_b0145","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","article-title":"Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis","volume":"136","author":"Dominguez","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cca.2023.117248_b0150","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/gutjnl-2015-310344","article-title":"Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors","volume":"66","author":"Wieser","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cca.2023.117248_b0155","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1189\/jlb.72.6.1109","article-title":"Chronic ethanol consumption by mice results in activated splenic T cells","volume":"72 (6)","author":"Song","year":"2002","journal-title":"J. Leukoc. Biol."},{"issue":"14","key":"10.1016\/j.cca.2023.117248_b0160","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.3390\/ijms22147485","article-title":"The immune system through the lens of alcohol intake and gut microbiota","volume":"22","author":"Calleja-Conde","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2023.117248_b0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1189\/jlb.4RU1016-450R","article-title":"Alcohol, aging, and innate immunity","volume":"102","author":"Boule","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.cca.2023.117248_b0170","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.mayocp.2020.08.020","article-title":"Sex differences in alcohol consumption and alcohol-associated liver disease","volume":"96","author":"Kezer","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.cca.2023.117248_b0175","doi-asserted-by":"crossref","unstructured":"G. Rahimi Kalateh Shah Mohammad, A. Ghahremanloo, A. Soltani, E. Fathi, S.I. Hashemy, Cytokines as potential combination agents with PD\u20101\/PD\u2010L1 blockade for cancer treatment, J. Cell. Physiol. 235 (7-8) (2020) 5449-5460.","DOI":"10.1002\/jcp.29491"},{"issue":"6","key":"10.1016\/j.cca.2023.117248_b0180","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41423-022-00848-3","article-title":"The combination of PD-1 blockade with interferon-\u03b1 has a synergistic effect on hepatocellular carcinoma","volume":"19","author":"Zhu","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cca.2023.117248_b0185","first-page":"1","article-title":"Prognostic models for alcoholic hepatitis","volume":"3 (1)","author":"Rahimi","year":"2015","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cca.2023.117248_b0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41575-022-00723-6","article-title":"Advancing alcohol-related liver disease: from novel biomarkers to refining selection for liver transplantation","volume":"20","author":"Arab","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.cca.2023.117248_b0195","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jhep.2018.11.025","article-title":"Non-invasive diagnosis and biomarkers in alcohol-related liver disease","volume":"70","author":"Moreno","year":"2019","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.cca.2023.117248_b0200","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/gutjnl-2019-319720","article-title":"Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting","volume":"69","author":"Avila","year":"2020","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cca.2023.117248_b0205","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41591-022-01850-y","article-title":"Noninvasive proteomic biomarkers for alcohol-related liver disease","volume":"28","author":"Niu","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2023.117248_b0210","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.29080","article-title":"A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis","volume":"66 (2)","author":"Bissonnette","year":"2017","journal-title":"Hepatology"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123000505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123000505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:08:02Z","timestamp":1757862482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123000505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":42,"alternative-id":["S0009898123000505"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117248","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles and correlations of TIM-3 and LAG-3 with cytokines and chemokines in alcoholic liver disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117248"}}